We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+31.27%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.91B
AUM Growth
+$590M
Cap. Flow
+$43.3M
Cap. Flow %
1.11%
Top 10 Hldgs %
41.55%
Holding
108
New
10
Increased
23
Reduced
13
Closed
15

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$49.2M
2
CRM icon
Salesforce
CRM
+$31.6M
3
RNAM
Avidity Biosciences
RNAM
+$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

Rank Stock Value
1
ETNB
89bio
ETNB
+$60.4M
2
GEHC icon
GE HealthCare
GEHC
+$39.4M
3
DKS icon
Dick's Sporting Goods
DKS
+$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 51.02%
2 Technology 11.4%
3 Consumer Discretionary 5.04%
4 Financials 4.79%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
51
Biogen
BIIB
$30.7B
$23.6M 0.6%
168,190
+16,300
+11% +$2.2M
MRVL icon
52
Marvell Technology
MRVL
$196B
$22.9M 0.59%
+272,300
New +$20M
NOW icon
53
ServiceNow
NOW
$129B
$20.2M 0.52%
+110,000
New +$20.5M
CTNM
54
Contineum Therapeutics
CTNM
$566M
$20.2M 0.52%
1,720,000
– –
SNOW icon
55
Snowflake
SNOW
$115B
$20.1M 0.52%
+89,200
New +$19.2M
GS icon
56
Goldman Sachs
GS
$303B
$19.2M 0.49%
24,108
– –
MRK icon
57
Merck
MRK
$318B
$18.4M 0.47%
219,178
– –
PINS icon
58
Pinterest
PINS
$13.4B
$16M 0.41%
497,185
+67,160
+16% +$2.44M
ABEO icon
59
Abeona Therapeutics
ABEO
$413M
$14.1M 0.36%
2,676,000
– –
RCKT icon
60
Rocket Pharmaceuticals
RCKT
$394M
$12.5M 0.32%
3,843,333
-300,000
-7% -$945K
REGN icon
61
Regeneron Pharmaceuticals
REGN
$80.8B
$9.97M 0.26%
17,730
+9,100
+105% +$5.15M
IFRX icon
62
InflaRx
IFRX
$271M
$8.69M 0.22%
6,483,910
– –
MOLN
63
Molecular Partners
MOLN
$8.24M 0.21%
2,221,494
– –
WHWK
64
Whitehawk Therapeutics
WHWK
$271M
$7.03M 0.18%
3,700,000
– –
ABT icon
65
Abbott
ABT
$187B
$6.83M 0.17%
51,020
+10,500
+26% +$1.38M
TMO icon
66
Thermo Fisher Scientific
TMO
$220B
$6.5M 0.17%
13,400
+5,500
+70% +$2.56M
STRO icon
67
Sutro Biopharma
STRO
$421M
$5.63M 0.14%
648,832
– –
EXAS
68
DELISTED
Exact Sciences
EXAS
$5.15M 0.13%
94,100
– –
ELAN icon
69
Elanco Animal Health
ELAN
$11.1B
$5.11M 0.13%
253,600
– –
COR icon
70
Cencora
COR
$61.2B
$3.9M 0.1%
12,488
– –
UTHR icon
71
United Therapeutics
UTHR
$23.1B
$3.14M 0.08%
+7,500
New +$2.52M
KZR
72
DELISTED
Kezar Life Sciences
KZR
$2.8M 0.07%
716,759
– –
MTD icon
73
Mettler-Toledo International
MTD
$28.6B
$2.41M 0.06%
1,964
– –
MDT icon
74
Medtronic
MDT
$112B
$2.39M 0.06%
25,060
– –
ISRG icon
75
Intuitive Surgical
ISRG
$134B
$2.33M 0.06%
5,200
– –
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Suvretta Capital Management held 108 positions worth $3.91B, up 18% from $3.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management's Q3 2025 filing shows 10 new, 23 increased, 13 reduced and 15 closed positions. Its largest new stake was Keurig Dr Pepper: 1,570,000 shares worth $40.1M. The largest sale was 89bio, an estimated $60.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q3 2025 buy was Keurig Dr Pepper: 1,570,000 shares worth $40.1M.
  • Suvretta Capital Management added most to Ferguson in Q3 2025, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q3 2025 reduction was 89bio, cutting an estimated $60.4M.
  • Suvretta Capital Management fully exited GE HealthCare in Q3 2025, selling an estimated $39.4M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.91B portfolio in Q3 2025.
  • Suvretta Capital Management opened 10 new positions and closed 15 in Q3 2025.
  • Suvretta Capital Management's portfolio value rose 18% quarter-over-quarter to $3.91B.

Based on Suvretta Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.